Bio-Rad Laboratories (BIO) Cash from Investing Activities (2016 - 2025)
Historic Cash from Investing Activities for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to -$34.2 million.
- Bio-Rad Laboratories' Cash from Investing Activities fell 1213.11% to -$34.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$189.7 million, marking a year-over-year decrease of 1841.45%. This contributed to the annual value of -$189.7 million for FY2025, which is 1841.45% down from last year.
- According to the latest figures from Q4 2025, Bio-Rad Laboratories' Cash from Investing Activities is -$34.2 million, which was down 1213.11% from -$43.0 million recorded in Q3 2025.
- Bio-Rad Laboratories' Cash from Investing Activities' 5-year high stood at $72.2 million during Q4 2023, with a 5-year trough of -$916.1 million in Q1 2022.
- Its 5-year average for Cash from Investing Activities is -$116.7 million, with a median of -$52.0 million in 2021.
- In the last 5 years, Bio-Rad Laboratories' Cash from Investing Activities tumbled by 179571.25% in 2022 and then skyrocketed by 22327.57% in 2023.
- Quarter analysis of 5 years shows Bio-Rad Laboratories' Cash from Investing Activities stood at -$567.4 million in 2021, then surged by 89.68% to -$58.6 million in 2022, then surged by 223.28% to $72.2 million in 2023, then plummeted by 142.25% to -$30.5 million in 2024, then decreased by 12.13% to -$34.2 million in 2025.
- Its Cash from Investing Activities was -$34.2 million in Q4 2025, compared to -$43.0 million in Q3 2025 and -$115.4 million in Q2 2025.